Vindesine Sulfate

HCID 43116CAS 59917-39-4

기본 정보

표준 SMILES
CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
InChIKey
COFJBSXICYYSKG-FJFFLIEUSA-N
분자식
C43H57N5O11S
평균 분자량
852 g/mol
단동위원소 질량
851.37752864

개요

Vindesine sulfate is an alkaloid sulfate salt. It has a role as an antineoplastic agent. It is functionally related to a vindesine.

이름 및 식별자

우선 이름
Vindesine Sulfate
IUPAC
methyl (13S,15S,17S)-13-[(1R,9R,10S,11R,12R,19R)-10-carbamoyl-12-ethyl-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate;sulfuric acid

이름 및 동의어

vindesine sulfate59917-39-4EldisineVindesine sulfate saltEldesineDTXSID0049074Desacetylvinblastine amide sulfateFildesin3-Carbamoyl-4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine sulfate (1:1) (salt)DTXCID0029000CHEBI:322953-carbamoyl-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine sulfate
이름 더 보기
NSC 245467LY-099094EldisinGesidineEnisonVindesini SulfasNSC-245467Sulfate, Vindesine

데이터베이스 식별자

CAS
59917-39-4
PubChem CID
43116
DTXSID
DTXSID0049074
ChEMBL
CHEMBL3989543
ChEBI
CHEBI:32295
EC Number
261-984-7

물성

구조 계산 물성

극성 표면적
248 Ų
수소 결합 공여자 수
7
수소 결합 수용자 수
14
회전 가능 결합 수
7
무거운 원자 수
60

안전 및 규제

GHS 분류

GHS Classification · 4건

Danger

H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]

P203, P264, P264+P265, P270, P280, P301+P316, P305+P354+P338, P317, P318, P321, P330, P405, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

유해성 정보

Hazard Classes and CategoriesAcute Tox. 2 (100%)

독성 정보

Treatment · 1건

Activated charcoal binds most toxic agents and can decrease their systemic absorption if administered soon after ingestion. Immediate dilution with milk or water may be of benefit in caustic or irritant chemical ingestions. If the exposure occurred through inhalation, move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with inhaled beta2 agonist and oral or parenteral corticosteroids. in case of acute lung injury, Maintain ventilation and oxygenation and evaluate with frequent arterial blood gas or pulse oximetry monitoring. Following eye exposure, irrigate exposed eyes with copious amounts of room temperature water for at least 15 minutes. In case of dermal exposure, Remove contaminated clothing and wash exposed area thoroughly with soap and water. Treat dermal irritation or burns with standard topical therapy. Patients developing dermal hypersensitivity reactions may require treatment with systemic or topical corticosteroids or antihistamines. (T36)

Health EffectsThe bone marrow depressant effects of vindesine may result in an increased incidence of microbial infection, delayed healing, and gingival bleeding (A609).
Exposure RoutesIngestion, inhalation (T36, A566).
Toxicity SummaryVindesine acts by causing the arrest of cells in metaphase mitosis through its inhibition tubulin mitotic funcitoning. The drug is cell-cycle specific for the S phase.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Toxicity DataLD50: 4 mg/kg (Mouse)

화학 및 산업

약리 정보

Metabolism/MetabolitesHepatic Half Life: 24 hours.
MeSH Pharmacological Classification · 2건

Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity.

Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES.

용도 및 제조

UsesVindesine is used in chemotherapy to treat many different types of cancer, including leukaemia, lymphoma, melanoma, breast cancer, and lung cancer (L1022).

관련 반응

0건

현재 필터 조건에 해당하는 반응 기록이 없습니다.

연결된 노트

불러오는 중…